Transforming genetic discoveries into groundbreaking treatments
We are accelerating the journey from genetic discovery to groundbreaking therapies in neurology, autoimmune diseases, and inflammatory skin conditions. By applying advanced bioinformatics and artificial intelligence, we eliminate major risks associated with traditional drug development while significantly reducing the cost and time to bring safe and effective treatments to millions of patients.
Our R&D efforts are operated by a team of international experts in genetics, genomics, bioinformatics, neurlology and immunology
– augmented by a world-class network of leading scientists and research institutions across the United States and Europe.
The Pulse
-
Arctic Therapeutics research suggests preventative strategy against HCCAA
Icelandic drug discovery and development company Arctic Therapeutics (ATx) today announced the publication of research in JAMA Neurology, which informs a possible therapeutic strategy to treat a rare form of familial dementia. N-acetylcysteine (NAC) shows promise to treat hereditary cystatin C amyloid angiopathy (HCCAA) HCCAA – a subtype of cerebral amyloid angiopathy (CAA) – is…
